Terkko Navigator / Radiotherapy & Oncology

Automatic segmentation of three clinical target volumes in radiotherapy using lifelong learning

Three large trials on radiotherapy for early breast cancer: What did we learn?

Patterns of palliative radiotherapy fractionation for brain metastases patients in New South Wales, Australia

Prognostic value of radiologic extranodal extension in patients with hypopharyngeal cancer treated with primary chemoradiation

The use of pentoxifylline, tocopherol and clodronate in the management of osteoradionecrosis of the jaws

Prolongation of definitive head and neck cancer radiotherapy: Survival impact and predisposing factors

Detection of an asymptomatic Covid-19 patient on CBCT-imaging

Pelvic insufficiency fractures following carbon-ion radiotherapy for uterine carcinomas

p38β (MAPK11) mediates gemcitabine-associated radiosensitivity in sarcoma experimental models

Single-fraction prostate stereotactic body radiotherapy: Dose reconstruction with electromagnetic intrafraction motion tracking

Normal tissue complication probability (NTCP) models of acute urinary toxicity (AUT) following carbon ion radiotherapy (CIRT) for prostate cancer

Multicentre, deep learning, synthetic-CT generation for ano-rectal MR-only radiotherapy treatment planning

Healthcare resource utilization following unilateral versus bilateral radiation therapy for oropharyngeal carcinoma

Prognostic influence of prevertebral space involvement in nasopharyngeal carcinoma: A retrospective study

Clinical oncology module for the ESTRO core curriculum

Deep learning prediction of proton and photon dose distributions for paediatric abdominal tumours

Pattern of failure in IDH mutated, low grade glioma after radiotherapy – Implications for margin reduction

Dosimetric impact of intrafraction prostate rotation and accuracy of gating, multi-leaf collimator tracking and couch tracking to manage rotation: An end-to-end validation using volumetric film measurements

The role of the gut microbiome on radiation therapy efficacy and gastrointestinal complications: A systematic review

Final results of a dose escalation protocol of stereotactic body radiotherapy for poor surgical candidates with localized renal cell carcinoma

COVID-19 safe and fully operational radiotherapy: An AIRO survey depicting the Italian landscape at the dawn of phase 2

Management of oligo-metastatic and oligo-recurrent cervical cancer: A pattern of care survey within the EMBRACE research network

Ureteral stenosis after 3D MRI-based brachytherapy for cervical cancer – Have we identified all the risk factors?

Salvage low dose rate brachytherapy for prostate cancer recurrence following definitive external beam radiation therapy

Definitive radiotherapy for prostate cancer in Norway 2006–2015: Temporal trends, performance and survival

Effect of radiotherapy interruption due to COVID-19 outbreak

Combining tumor response and personalized risk assessment: Potential for adaptation of concurrent chemotherapy in locoregionally advanced nasopharyngeal carcinoma in the intensity-modulated radiotherapy era

Immune cell profiling in Gleason 9 prostate cancer patients treated with brachytherapy versus external beam radiotherapy: An exploratory study

Patient-reported functional outcomes following external beam radiation therapy for prostate cancer with and without a high-dose rate brachytherapy boost: A national population-based study

Identification of the mutation signature of the cancer genome caused by irradiation

Patient-reported outcomes after external beam radiotherapy versus brachytherapy for palliation of dysphagia in esophageal cancer: A matched comparison of two prospective trials

A qualitative classification signature for post-surgery 5-fluorouracil-based adjuvant chemoradiotherapy in gastric cancer

Results of phase II trial of intensified neoadjuvant treatment with interdigitating radiotherapy and chemotherapy with oxaliplatin, 5-fluorouracil and folinic acid in patients with locally advanced rectal cancer (PROARCT trial)

Hypofractionated radiation therapy for breast cancer: Preferences amongst radiation oncologists in Europe – Results from an international survey

Early alteration in apparent diffusion coefficient and tumor volume in cervical cancer treated with chemoradiotherapy or radiotherapy: Incremental prognostic value over pretreatment assessments

Dose–response with stereotactic body radiotherapy for prostate cancer: A multi-institutional analysis of prostate-specific antigen kinetics and biochemical control

Randomised trial of external-beam radiotherapy alone or with high-dose-rate brachytherapy for prostate cancer: Mature 12-year results

Lead-time bias does not falsify the efficacy of early salvage radiotherapy for recurrent prostate cancer

In response to: “Intraoperative radiation therapy (IORT) for soft tissue sarcoma – ESTRO IORT task force/ACROP recommendations”

Can radiation-recall predict long lasting response to immune checkpoint inhibitors?

Inter-fraction motion robustness and organ sparing potential of proton therapy for cervical cancer

Inter/intra-tumoral dose response variations assessed using FDG-PET/CT feedback images: Impact on tumor control and treatment dose prescription

Radiation-induced lymphopenia during chemoradiation therapy for non-small cell lung cancer is linked with age, lung V5, and XRCC1 rs25487 genotypes in lymphocytes

Dose volume histogram constraints in patients with head and neck cancer treated with surgery and adjuvant HDR brachytherapy: A proposal of the head and neck and skin GEC ESTRO Working group

Letter to the editor concerning Offersen et al., [Radiother Oncol 2015; 114: 3–10]

Challenges influencing the utilization of prostate brachytherapy in the United States

Integrating cullin2-RING E3 ligase as a potential biomarker for glioblastoma multiforme prognosis and radiosensitivity profiling

High-throughput meta-analysis and validation of differentially expressed genes as potential biomarkers of ionizing radiation-response

Head and neck IMPT probabilistic dose accumulation: Feasibility of a 2 mm setup uncertainty setting

Clinical implementation of 3D in vivo dosimetry for abdominal and pelvic stereotactic treatments